This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Toronto directory, so their courses and email address may be missing. Find their university profile.
Research
Latest papers
Safety of intravascular administration of umbilical-cord-derived mesenchymal stromal cells: an updated systematic review and meta-analysis.
Stem cells translational medicine · 2026
Selective Decontamination of the Digestive Tract during Ventilation in the ICU.
The New England journal of medicine · 2026
Procalcitonin to Guide 7 vs 14 Days of Antibiotics in Bloodstream Infections
JAMA Network Open · 2026
Latest funding
- $19,725
Symposium on Corticosteroids in Critical Illness - What do we still not understand?
CIHR · 2025 · Principal investigator
- $2,952,135
Precision medicine Adaptive Network platform Trial in Hypoxemic acutE respiratory failuRe (PANTHER)
CIHR · 2025 · Co-investigator
- $100,000
Precision medicine Adaptive Network platform Trial in Hypoxemic acutE respiratory failuRe (PANTHER)
CIHR · 2025 · Co-investigator
82 publications.
Safety of intravascular administration of umbilical-cord-derived mesenchymal stromal cells: an updated systematic review and meta-analysis.
Hum C, Poliwoda J, Lalu M, Stewart DJ, Mei SHJ, Walley KR, Marshall J, Mendelson AA, Fergusson DA, English S, Winston BW, Granton J, Dos Santos CC, Champagne J, McIntyre L
Selective Decontamination of the Digestive Tract during Ventilation in the ICU.
SuDDICU Investigators for the Australia and New Zealand Intensive Care Society Clinical Trials Group and the Canadian Critical Care Trials Group, Cuthbertson BH, Billot L, Campbell MK, Daneman N, Davis JS, Delaney A, Devaux A, Ferguson ND, Finfer SR, Fowler R, Gordon AC, Hammond NE, Klein G, Li Q, Marshall J, Micallef S, Murthy S, Mysore J, Naik C, Patel C, Pinto R, Rose L, Seppelt IM, Venkatesh B, Young PJ, Myburgh JA, The SuDDICU Investigators for the Australia and New Zealand Intensive Care Society Clinical Trials Group and the Canadian Critical Care Trials Group
Procalcitonin to Guide 7 vs 14 Days of Antibiotics in Bloodstream Infections
Ramendra R, Wright JK, Kain KC, Kim B, Mishra H, Zhong K, Aslanian P, Carignan A, Conly J, Detsky M
Antibiotic Treatment for 7 versus 14 Days in Patients with Bloodstream Infections
Daneman N, Rishu A, Pinto R, Rogers BA, Shehabi Y, Parke R, Cook D, Arabi Y, Muscedere J, Reynolds S
A Crossover Trial of Hospital-Wide Lactated Ringer’s Solution versus Normal Saline
McIntyre L, Fergusson D, McArdle T, English S, Cook DJ, Fox-Robichaud AE, Martin C, Marshall J, Pugliese M, Menon K
Impact of Antibiotic Duration on Gut Microbiome Composition and Antimicrobial Resistance: A Substudy of the BALANCE Randomized Controlled Trial
Armstrong E, Kulikova M, Yee N, Rishu A, Muscedere J, Sibley S, Maslove D, Boyd JG, Evans G, Detsky M
Coenrollment of critically ill patients in PROSPECT: characteristics and association with treatment efficacy and safety
Thabane A, Heels-Ansdell D, Zytaruk N, Johnstone J, Lauzier F, Arabi YM, Muscedere J, Clarke F, Hand L, Watpool I
Using a targeted metabolomics approach to explore differences in ARDS associated with COVID-19 compared to ARDS caused by H1N1 influenza and bacterial pneumonia.
Lee CH, Banoei MM, Ansari M, Cheng MP, Lamontagne F, Griesdale D, Lasry DE, Demir K, Dhingra V, Tran KC, Lee T, Burns K, Sweet D, Marshall J, Slutsky A, Murthy S, Singer J, Patrick DM, Lee TC, Boyd JH, Walley KR, Fowler R, Haljan G, Vinh DC, Mcgeer A, Maslove D, Mann P, Donohoe K, Hernandez G, Rocheleau G, Trahtemberg U, Kumar A, Lou M, Dos Santos C, Baker A, Russell JA, Winston BW, *ARBs CORONA I. Investigators
Causal inference can lead us to modifiable mechanisms and informative archetypes in sepsis.
Baillie JK, Angus D, Burnham K, Calandra T, Calfee C, Gutteridge A, Hacohen N, Khatri P, Langley R, Ma'ayan A, Marshall J, Maslove D, Prescott HC, Rowan K, Scicluna BP, Seymour C, Shankar-Hari M, Shapiro N, Joost Wiersinga W, Singer M, Randolph AG
Sodium-glucose co-transporter-2 inhibitors for hospitalised patients with COVID-19: a prospective meta-analysis of randomised trials.
Vale C, Godolphin PJ, Fisher D, Horby PW, Kosiborod MN, Hochman JS, Webster K, Higgins JPT, Althouse AD, Berwanger O, Furtado RHM, Gasparyan SB, Haynes R, Koch GG, Landray M, Leifer E, Marshall J, Murthy S, Neal MD, Staplin N, Diaz J, Sterne JAC, Shankar-Hari M, WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group
Symposium on Corticosteroids in Critical Illness - What do we still not understand?
Principal investigators: Teja, Bijan J; Marshall, John C; Mazer, David
Keywords: Adaptive Platform Trial; Corticosteroids; Critical Care
Precision medicine Adaptive Network platform Trial in Hypoxemic acutE respiratory failuRe (PANTHER)
Principal investigators: Ferguson, Niall D; Calfee, Carolyn; McAuley, Danny
Keywords: Acute Hypoxemic Respiratory Failure; Platform Trial; Precision Medicine
Precision medicine Adaptive Network platform Trial in Hypoxemic acutE respiratory failuRe (PANTHER)
Principal investigators: Ferguson, Niall D; Calfee, Carolyn; McAuley, Danny
Keywords: Acute Hypoxemic Respiratory Failure; Platform Trial; Precision Medicine
Adaptive platform trials in pandemics: Evaluating COVID-19 case studies and developing guidelines for future health emergencies
Principal investigators: Hosseini, Benita; Pinto, Andrew D
Keywords: Adaptive Platform Trials (Apts); Comparative Case Study; Guidelines Development; Pandemic Preparedness
The Randomized Embedded Multifactorial Adaptive Platform Trial in Community-Acquired Pneumonia (REMAP-CAP): Enshrining a Global Pandemic Research Response to COVID-19 and Beyond
Principal investigators: Marshall, John C; Dalziel, Sandra; Kho, Michelle E; Lamontagne, Francois; Leligdowicz, Aleksandra; Murthy, Srinivas; Park, Jay; Smith, Kathleen F
Keywords: Acute Organ Dysfunction; Covid-19; Critical Illness; Global Health; Hemodynamic Management; Platform Trial; Research Collaboration; Ventilatory Support
Canadian Critical Care Trials Group COVID-19 Response: defining critical care capacity in Canada; testing treatments through large-scale adaptive clinical trials; & establishing the evidence base to inform clinical and health system management decisions
Principal investigators: Fowler, Robert A; Adhikari, Neill K; Archambault, Patrick; Bagshaw, Sean M; Binnie, Alexandra; Chasse, Michael; Cook, Deborah J; Daneman, Nick; Fiest, Kirsten M; Fox-Robichaud, Alison E; Goligher, Ewan C; Herridge, Margaret S; Kho, Michelle E; Lamontagne, Francois; Lawler, Patrick R; Lee, Todd C; Marshall, John C; McDonald, Emily G; McNally, James D; Meade, Maureen O; Mehta, Sangeeta; Menon, Kusum; Murthy, Srinivas; O'Hearn, Katharine J; Piquette, Dominique; Rochwerg, Bram N; Russell, James A; Tsang, Jennifer L; Turgeon, Alexis F; Wollny, Krista; Yada, Nicole; Zarychanski, Ryan
Keywords: Clinical Trials; Covid-19; Network
BALANCE+: A Platform Trial for Gram Negative Bloodstream Infections
Principal investigators: Daneman, Nick; Murthy, Srinivas; Yamamura, Deborah L; Fowler, Robert A; Johnstone, Jennie; Lee, Todd C; MacFadden, Derek R; McDonald, Emily G; Paterson, David L; Rogers, Benjamin A; Yahav, Dafna
Keywords: Adaptive Platform Trial; Antibiotic De-Escalation; Antibiotic Step-Down; Antimicrobial Resistance; Bloodstream Infection; Central Venous Catheter Infection; Gram Negative Bacteremia; Randomized Controlled Trial
The Clinical Evaluation of Adults Undergoing Elective Surgery Utilizing Intraoperative Incisional Wound Irrigation (CLEAN Wound) Trial
Principal investigators: Karanicolas, Paul J; Abou Khalil, Jad; Smith, David E; Tsang, Melanie E; Mason, Stephanie
Keywords: Adaptive Trial Design; Innovative Clinical Trials; Intraoperative Interventions; Perioperative Care; Pragmatic Trials; Surgery
Canadian ADAptive Platform Trial of COVID-19 Therapeutics in Community Settings (Can-ADAPT COVID)
Principal investigators: Pinto, Andrew D; Keynan, Yoav; Greiver, Michelle; Jüni, Peter; Lee, Todd C; McDonald, Emily G; Murthy, Srinivas; Selby, Peter L
Keywords: Adaptive Platform Trial; Covid-19; Nirmatrelvir; Out-Patient; Sars-Cov-2; Therapeutics
The Randomized Embedded Multifactorial Adaptive Platform Trial in Community-Acquired Pneumonia (REMAP-CAP): Enshrining a Global Pandemic Research Response to COVID-19 and Beyond
Principal investigators: Marshall, John C; Dalziel, Sandra; Kho, Michelle E; Lamontagne, Francois; Leligdowicz, Aleksandra; Murthy, Srinivas; Park, Jay; Smith, Kathleen F
Keywords: Acute Organ Dysfunction; Covid-19; Critical Illness; Global Health; Hemodynamic Management; Platform Trial; Research Collaboration; Ventilatory Support
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Medicine
- Critical Care Medicine
- Health Research Methods, Evidence, and Impact
- Infectious Diseases/Internal Medicine
- Clinical Epidemiology
- Médecine interne
- Internal Medicine
- Other
Co-authors at University of Toronto, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
Deborah Cook
Medicine
23 shared papers, latest 2025
Lauralyn McIntyre
Clinical Epidemiology
16 shared papers, latest 2026
John Muscedere
Critical Care Medicine
15 shared papers, latest 2026
Srinivas Murthy
Faculty
12 shared papers, latest 2026
Diane Heels-Ansdell
Health Research Methods, Evidence, and Impact
11 shared papers, latest 2025
Francois Lamontagne
Médecine interne
11 shared papers, latest 2026
Ryan Zarychanski
Internal Medicine
10 shared papers, latest 2025
Jennifer Tsang
Medicine
10 shared papers, latest 2026
Shane English
Regenerative Medicine
10 shared papers, latest 2026
Erick Duan
Medicine
9 shared papers, latest 2026
Anand Kumar
General Internal Medicine
8 shared papers, latest 2025
Nick Daneman
Infectious Diseases/Internal Medicine
8 shared papers, latest 2026
Bram Rochwerg
Health Research Methods, Evidence, and Impact
8 shared papers, latest 2025
Jennie Johnstone
Clinical Public Health Division
7 shared papers, latest 2025
Lehana Thabane
Health Research Methods, Evidence, and Impact
7 shared papers, latest 2024
Alison Fox-Robichaud
Medicine
7 shared papers, latest 2025
Robert Fowler
Infectious Diseases/Internal Medicine
7 shared papers, latest 2026
Claudio Martin
Faculty
7 shared papers, latest 2025
Ian Ball
Department of Epidemiology and Biostatistics
6 shared papers, latest 2025
Peter Dodek
Medicine
6 shared papers, latest 2025
Joanna Dionne
Medicine
6 shared papers, latest 2024
Timothy A Karachi
Medicine
6 shared papers, latest 2025
Sangeeta Mehta
Faculty
5 shared papers, latest 2024
David Maslove
Critical Care Medicine
5 shared papers, latest 2025
John Granton
Medicine/Respirology
5 shared papers, latest 2026
Monica Taljaard
School of Epidemiology and Public Health
5 shared papers, latest 2025
François Lauzier
Anesthesiology & Critical Care Medicine
5 shared papers, latest 2026
Manoj Lalu
Anesthesiology
4 shared papers, latest 2026
Kednapa Thavorn
Faculty
4 shared papers, latest 2025
John Marshall
Faculty
4 shared papers, latest 2024
Raphael Saginur
Department of Medicine
4 shared papers, latest 2025
Steven Hawken
School of Epidemiology and Public Health
4 shared papers, latest 2025
Karen Tran
Faculty
3 shared papers, latest 2022
Daniel Niven
Critical Care Medicine
3 shared papers, latest 2024
Alexandra Binnie
Critical Care Medicine
3 shared papers, latest 2024
Anand Kumar
Medicine
3 shared papers, latest 2020
Michael Detsky
Faculty
3 shared papers, latest 2026
Ruxandra Pinto
Infectious Diseases/Internal Medicine
3 shared papers, latest 2026
Bryan Coburn
Cell and Systems Biology
2 shared papers, latest 2025
John Conly
Medicine
2 shared papers, latest 2026
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.